Finanzen von Tourmaline Bio Inc (TRML)TRMLTourmaline Bio Inc

Evaluating the bottom line, Tourmaline Bio Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -29.62%, provide a clear picture of how effectively TRML converts its operational activities into shareholder value.

In the context of the broader market, TRML competes directly with industry leaders such as IMTX and ELVN. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, TRML's gross margin of N/A stands against IMTX's 100.00% and ELVN's N/A. Such benchmarking helps identify whether Tourmaline Bio Inc is trading at a premium or discount relative to its financial performance.